Amicus Therapeutics Inc (FOLD) — Capital Reinvestment Ratio
Amicus Therapeutics Inc (FOLD) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($299.00K). Check how tangible is Amicus Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amicus Therapeutics Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks Amicus Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see FOLD cash flow metrics.
Annual Capital Reinvestment Ratio for Amicus Therapeutics Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for Amicus Therapeutics Inc from 2007 to 2025. See free cash flow generation of Amicus Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $33.15 Million | $3.30 Million | ▲ +125.8% |
| 2007 | 0.04x | $15.19 Million | $669.00K | — |